leisure time -WSS

leisure time

author：knowledge 2025-09-30 08:15:07 - browse：829

Sterile capsules for injection line up in a dispensing line — politics coverage from STAT — Adobe

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs.

Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists. Shortages are primarily a problem for hospitals and doctors who regularly administer drugs, including oncologists who have been running out of common chemo drugs. Generic injectables account for 67% of shortages, and more than half of drugs in short supply cost less than $1 per unit, according to the Finance Committee.

Hospitals band together to negotiate drug prices by hiring group purchasing organizations. The biggest three GPOs are estimated to control about 90% of the market for drugs that hospitals buy. Finance Chair Ron Wyden (D-Ore.) said those GPOs can drive prices down so low that manufacturers stop making certain drugs or can’t afford to maintain their facilities, which then leads to manufacturing interruptions. Drugmakers also say GPOs can also be fickle, switching from one manufacturer to another over small savings, leaving drugmakers without the certainty they need to commit to making large volumes of product.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： ACIP vaccine advisory panel sees its vacancies filled

explore

WSS

Readout LOUD podcast: Live from the 2023 STAT Summit

ACIP vaccine advisory panel sees its vacancies filled

Tome Biosciences co

Study gives hint on South Asians’ higher risk of cardiovascular disease

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

UnitedHealth, Optum discontinue NaviHealth name

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

knowledge

Medicare details structure of new drug price negotiation program

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Results on Novartis prostate cancer therapy could expand its use

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Long Covid research funding gets a major boost from NIH

Moonlake's readout produced a cash windfall. Risks remain

STAT Summit: Ending the crisis of Black deaths in the U.S.

George Santos makes 1st court appearance after pleading not guilty to 13 counts

ADCs take center stage as promising cancer treatments

entertainment

Juul documents reveal insider tactics on political lobbying

AMAs digital advisors table RPM coding reform proposal, again

ACIP vaccine advisory panel sees its vacancies filled

Having children helps parents live longer, especially after age 80

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Eli Lilly reports tirzepatide MASH success during Q4 earnings

leisure time

explore

focus

knowledge